Recent treatments of interstitial lung disease with systemic sclerosis

Hidekata Yasuoka

研究成果: Article査読

13 被引用数 (Scopus)

抄録

Systemic sclerosis (SSc) is a disorder characterized by immune dysfunction, microvascular injury, and fibrosis. Organ involvement in patients with SSc is variable; however, pulmonary involvement occurs in up to 90% of patients with SSc. Interstitial lung disease (ILD) is a major cause of mortality and, thus, a major determinant in the prognosis of patients with SSc. This review summarizes current findings about the characteristics of ILD in patients with SSc, selection of patients with SSc-ILD who are candidates for the treatment, and current treatment options.

本文言語English
ページ(範囲)97-110
ページ数14
ジャーナルClinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine
9
DOI
出版ステータスPublished - 2016 1 19

ASJC Scopus subject areas

  • 呼吸器内科
  • 循環器および心血管医学

フィンガープリント

「Recent treatments of interstitial lung disease with systemic sclerosis」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル